111 related articles for article (PubMed ID: 25424500)
1. Study "guesstimated" how many cancers would have occurred without mammography screening.
Kopans DB
BMJ; 2014 Nov; 349():g6824. PubMed ID: 25424500
[No Abstract] [Full Text] [Related]
2. Mammography screening study hampered by inadequate data.
Tabár L
BMJ; 2014 Nov; 349():g6823. PubMed ID: 25424720
[No Abstract] [Full Text] [Related]
3. Stable incidence of advanced breast cancer argues against screening effectiveness.
Autier P; Pizot C; Boniol M
BMJ; 2014 Nov; 349():g6358. PubMed ID: 25424316
[No Abstract] [Full Text] [Related]
4. Authors' reply to Tabár and Kopans.
de Glas NA; Liefers GJ
BMJ; 2014 Nov; 349():g6828. PubMed ID: 25425291
[No Abstract] [Full Text] [Related]
5. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
6. Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study.
de Glas NA; de Craen AJ; Bastiaannet E; Op 't Land EG; Kiderlen M; van de Water W; Siesling S; Portielje JE; Schuttevaer HM; de Bock GT; van de Velde CJ; Liefers GJ
BMJ; 2014 Sep; 349():g5410. PubMed ID: 25224469
[TBL] [Abstract][Full Text] [Related]
7. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
[TBL] [Abstract][Full Text] [Related]
8. Effect of organised mammography screening on stage-specific incidence in Norway: population study.
Lousdal ML; Kristiansen IS; Møller B; Støvring H
Br J Cancer; 2016 Mar; 114(5):590-6. PubMed ID: 26835975
[TBL] [Abstract][Full Text] [Related]
9. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
Luke C; Priest K; Roder D
Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
[TBL] [Abstract][Full Text] [Related]
10. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
[TBL] [Abstract][Full Text] [Related]
12. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
[TBL] [Abstract][Full Text] [Related]
13. Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality.
Barratt A
BMJ; 2015 Mar; 350():h867. PubMed ID: 25736426
[No Abstract] [Full Text] [Related]
14. [Pathological characteristics in screening versus clinically-detected breast cancer].
Paziault M; Terrade FX; Fermeaux V; Pascal B; Darreye G; Dussartre C; Gilquin M; Labrousse F; Tubiana-Mathieu N
Bull Cancer; 2006 Jul; 93(7):731-6. PubMed ID: 16873082
[TBL] [Abstract][Full Text] [Related]
15. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
16. Retrospective quantification of background incidence and stage distribution of breast cancer for the mammography screening pilot project in Wiesbaden, Germany.
Schott G; Reichel M; Junkermann H; Becker N
J Cancer Res Clin Oncol; 2008 Jan; 134(1):29-35. PubMed ID: 17602243
[TBL] [Abstract][Full Text] [Related]
17. Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983-2007.
Puig-Vives M; Pollan M; Rue M; Osca-Gelis G; Saez M; Izquierdo A; Marcos-Gragera R
Breast; 2012 Oct; 21(5):646-51. PubMed ID: 22340960
[TBL] [Abstract][Full Text] [Related]
18. StatBite: Percent change in DCIS, invasive breast cancer, and mammography.
J Natl Cancer Inst; 2011 Mar; 103(6):457. PubMed ID: 21393608
[No Abstract] [Full Text] [Related]
19. Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium.
Allison KH; Abraham LA; Weaver DL; Tosteson AN; Nelson HD; Onega T; Geller BM; Kerlikowske K; Carney PA; Ichikawa LE; Buist DS; Elmore JG
Cancer; 2015 May; 121(9):1369-78. PubMed ID: 25603785
[TBL] [Abstract][Full Text] [Related]
20. Detection of ductal carcinoma in situ and subsequent interval cancers.
Shieh Y; Eklund M; Esserman L
BMJ; 2016 Feb; 352():i551. PubMed ID: 26834245
[No Abstract] [Full Text] [Related]
[Next] [New Search]
